8:55 Welcome and Introductions
9:00 The Dobbs Decision and Its Ramifications
Meghan Boone, Wake Forest University School of Law, Winston-Salem
Christopher A. Brook, Patterson Harkavy LLP, Chapel Hill (Moderator)
James R. Lawrence III, Envisage Law, Raleigh
This panel discusses the holding and ramifications of the Supreme Court's decision in Dobbs v. Jackson Women's Health, 597 U.S. ___ (2022), which upended nearly 50 years of precedent established by Roe v. Wade. The session delves into the majority opinion, as well as the concurrences and dissents of various justices, turning to the current and potential implications for federal constitutional privacy and due process rights in the future.
10:00 Break
10:10 Dobbs in the States: Surveying the New Landscape of Access to Abortion
Marcus Gadson, Campbell Law School, Raleigh
Kristi L. Graunke, ACLU of North Carolina Legal Foundation, Raleigh (Moderator)
Jaclyn A. "Jaci" Maffetore, ACLU of North Carolina Legal Foundation, Raleigh
In Dobbs, the Supreme Court stated its intent to "return" the issue of access to abortion care to "the people and their elected representatives." This panel examines how the devolution of authority to regulate abortion has played out in various states, with particular attention to recent legislative and litigation developments in North Carolina. Topics include trigger laws reinstating old abortion bans; new state legislation to ban, restrict or secure abortion rights; post-Dobbs state supreme court decisions addressing state constitutional rights to abortion care; and state ballot initiatives.
11:10 Break
11:20 Medication Abortion After Dobbs
Susanna S. Birdsong, Planned Parenthood South Atlantic, Raleigh
Skye Perryman, Democracy Forward, Washington, DC
Muneeba Talukder, ACLU of North Carolina Legal Foundation, Raleigh (Moderator)
While Dobbs purported to leave decisions about access to the states, a new frontier of litigation has emerged around the Food and Drug Administration's authority to facilitate and expand access to mifepristone, one of the drugs most commonly used for abortion in the United States. Our expert panel gives an overview of the major lawsuits surrounding access to and use of mifepristone, with special attention to paths the Supreme Court may take to resolve these disputes in the near future.
12:20 Adjourn
Click here to view Forms and CLE Policies, Terms and Conditions.
If paying by check,
click here for a printable registration form. Please reference the live webcast program code 202LWC.
Certificate of Completion and Archived Video: Your certificate of completion and archived video will be available approximately two weeks of the program date and can be found in your CLE account. MCLE credit is available to registrants only on the day(s) of the live event. This archived content is offered solely for review purposes and is not a substitute for live attendance. Click here for more information about archive videos in our FAQ.